(Total Views: 268)
Posted On: 12/05/2022 8:55:47 AM
Post# of 45
$ZYNE News Article - Zynerba Pharmaceuticals Announces Positive Long-Term Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at the Annual Meeting of the American College of Neuropsychopharmacology https://marketwirenews.com/news-releases/zyne...49741.html
(0)
(0)
My Twitter: WhyteStocks
